Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Starling Oncology, Inc.

Starling Oncology, Inc. (STLN) Stock Overview

Explore Starling Oncology, Inc.’s financial performance, market position, analyst ratings, and future outlook.

STLN●NASDAQ
HealthcareMedical - Care Facilities
$6.45
$0.19(3.04%)
U.S. Market opens in 48h 24m

Starling Oncology, Inc. (STLN)

Meyka AI Score

Z

Key Financials

Market Cap644.9M
P/E Ratio-21.68
EPS (TTM)N/A
ROE2.10%
Fundamental Analysis

AI Price Forecasts

1 Month$13.86
3 Months$37.74
1 Year TargetN/A

STLN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Starling Oncology, Inc. (NASDAQ: STLN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Starling Oncology, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of STLN on the NASDAQ shows an RSI of 57.40, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Starling Oncology, Inc.'s NASDAQ-traded stock include a P/E ratio of -21.68 and a market capitalization of 644.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of STLN on the NASDAQ.

Price Performance (NASDAQ: STLN)

1-Day Change
3.04%
5-Day Change
-1.23%
1-Month Change
2.71%
3-Month Change
11.21%
6-Month Change
11.21%
Year-to-Date (YTD) Change
11.21%
1-Year Change
11.21%
3-Year Change
11.21%
5-Year Change
11.21%
All-Time (Max) Change
11.21%

Contact Information

https://www.starlingoncology.com
NaN
18000 Studebaker Road, Suite 800, Cerritos, CA, 90703

Company Facts

IPO DateAug 4, 2026
CountryUS
Actively Trading

Frequently Asked Questions